REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vinayak Remedies Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Vinayak Remedies Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vinayak Remedies Limited is an unlisted company, incorporated on 24/02/2006. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL2006PLC146801 and registration number is 146801. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Plot No-273, Pocket-D, Dsidc, Udyog Vihar Sector-3, Bawana
North Delhi; Delhi; Postal Code: 110039

Contact Details: Purchase the Vinayak Remedies Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vinayak Remedies Limited report to view the information.
Registered Capital:
Purchase the Vinayak Remedies Limited report to view the information.
Incorporation Date:
February 24, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
58.57%
Company Performance
Financial values in the chart are available after Vinayak Remedies Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.8%▼
Total operating revenue
-8.86%▼
Operating profit (EBIT)
-60.22%▼
EBITDA
-58.41%▼
Net Profit (Loss) for the Period
-43.48%▼
Total assets
7.34%▲
Total equity
11.47%▲
Operating Profit Margin (ROS)
-0.73%▼
Net Profit Margin
-0.32%▼
Return on Equity (ROE)
-10.01%▼
Debt to Equity Ratio
-10.97%▼
Quick Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo